Trial · NCT01677507

Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Initial Assignment	STARTED	Timolol Followed by Latanoprost	63
Initial Assignment	STARTED	Latanoprost Followed by Timolol	58
Initial Assignment	COMPLETED	Timolol Followed by Latanoprost	63
Initial Assignment	COMPLETED	Latanoprost Followed by Timolol	56
Initial Assignment	NOT COMPLETED	Timolol Followed by Latanoprost	0
Initial Assignment	NOT COMPLETED	Latanoprost Followed by Timolol	2
Second Assigment	STARTED	Timolol Followed by Latanoprost	63
Second Assigment	STARTED	Latanoprost Followed by Timolol	56
Second Assigment	COMPLETED	Timolol Followed by Latanoprost	60
Second Assigment	COMPLETED	Latanoprost Followed by Timolol	51
Second Assigment	NOT COMPLETED	Timolol Followed by Latanoprost	3
Second Assigment	NOT COMPLETED	Latanoprost Followed by Timolol	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01677507/flow